DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Wiewrodt R, Serke M, Grohe C et al.
Employing tyrosine kinase inhibitors in the first line treatment of EGFR-positive metastatic NSCLC – state of the art and recent developments.
Pneumologie 2013;
67: 494-501
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.